CROI

Antiviral should have been recommended sooner for non-ventilated patients, editorialist argues

Trial shows noninferiority to daily antiretroviral pills for controlling HIV

Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing

Losing streak continues for controversial antiparasitic

Half of kids under age 5 not diagnosed before death, CHAMPS study found

Exploratory analyses also point to possible reduction in long COVID symptoms

However, these rebound cases were rare and lasted only about 1 day

Substudy of HPTN 083 trial examined differences in outcomes by race among U.S. participants

Trial results came as a surprise after success in prophylaxis for other groups

Sutezolid may be a replacement for linezolid in these patients, researcher says

8-week regimen, with more for persistent cases, yields similar outcomes to 6-month standard

CDC researchers found a substantial minority of patients had never been tested

Screening followed by aggressive therapy shows benefit in phase III ANCHOR study

Intramuscular version of monoclonal antibody on par with infusion